当前位置:首页 - 行情中心 - 迈普医学(301033) - 财务分析 - 现金流量表

迈普医学

(301033)

  

流通市值:41.32亿  总市值:49.09亿
流通股本:5606.74万   总股本:6661.19万

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金183,049,028.0280,556,137.62304,523,588.74219,229,236.22
  收到的税费返还338,924.9-3,481,891.981,031,756.61
  收到其他与经营活动有关的现金2,442,205.2812,465,768.7333,047,736.149,497,963.61
  经营活动现金流入小计185,830,158.293,021,906.35341,053,216.86229,758,956.44
  购买商品、接受劳务支付的现金19,733,698.597,641,759.249,544,801.2833,085,736.44
  支付给职工以及为职工支付的现金47,411,634.5227,616,516.7772,614,589.4455,042,099.05
  支付的各项税费24,736,660.9912,591,901.7242,181,158.3628,224,138.83
  支付其他与经营活动有关的现金37,427,210.815,966,981.6360,328,314.7950,029,627.09
  经营活动现金流出小计129,309,204.963,817,159.32224,668,863.87166,381,601.41
  经营活动产生的现金流量净额56,520,953.329,204,747.03116,384,352.9963,377,355.03
二、投资活动产生的现金流量:
  收回投资收到的现金344,892,252.41164,034,454.41436,499,839.26352,260,181.97
  取得投资收益收到的现金-24,8502,100--
  处置固定资产、无形资产和其他长期资产收回的现金净额50,766.9265030,150.3418,500
  投资活动现金流入小计344,918,169.33164,037,204.41436,529,989.6352,278,681.97
  购建固定资产、无形资产和其他长期资产支付的现金9,566,325.414,504,502.2233,162,998.1725,631,341.08
  投资支付的现金375,654,794217,319,275411,696,920294,725,900
  投资活动现金流出小计385,221,119.41221,823,777.22444,859,918.17320,357,241.08
  投资活动产生的现金流量净额-40,302,950.08-57,786,572.81-8,329,928.5731,921,440.89
三、筹资活动产生的现金流量:
  吸收投资收到的现金--9,312,1929,312,192
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--9,312,1929,312,192
  偿还债务支付的现金--50,299,348.4450,299,348.44
  分配股利、利润或偿付利息支付的现金39,696,972.91-27,135,621.1926,261,817.43
  支付其他与筹资活动有关的现金791,169.8510,502.213,546,790.4713,036,288.27
  筹资活动现金流出小计40,488,142.71510,502.290,981,760.189,597,454.14
  筹资活动产生的现金流量净额-40,488,142.71-510,502.2-81,669,568.1-80,285,262.14
四、汇率变动对现金及现金等价物的影响495,324.34169,295.21156,134.77105,510.32
五、现金及现金等价物净增加额-23,774,815.15-28,923,032.7726,540,991.0915,119,044.1
  加:期初现金及现金等价物余额53,217,601.2753,217,601.2726,676,610.1826,676,610.18
  期末现金及现金等价物余额29,442,786.1224,294,568.553,217,601.2741,795,654.28
补充资料:
  净利润47,299,142.7-78,854,230.23-
  资产减值准备-23,067.44-165,805.78-
  固定资产和投资性房地产折旧9,387,949.9-18,722,100.68-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧9,387,949.9-18,722,100.68-
  无形资产摊销4,007,817.59-6,981,866.89-
  长期待摊费用摊销381,918.21-786,620.57-
  处置固定资产、无形资产和其他长期资产的损失---790.78-
  固定资产报废损失2,106,750.41-483,413.21-
  公允价值变动损失446,766.21--151,575.36-
  财务费用-1,374,104.05--1,228,423.41-
  投资损失-1,785,129.36--3,428,431.47-
  递延所得税-411,822.16--3,012,035.52-
  其中:递延所得税资产减少-69,354.19--3,046,522.23-
    递延所得税负债增加-342,467.97-34,486.71-
  存货的减少-3,696,398.97--8,148,118.89-
  经营性应收项目的减少7,005,958.55--4,426,627.74-
  经营性应付项目的增加-7,484,739.1-16,182,389.43-
  其他--13,181,143.62-
  现金的期末余额29,442,786.12-53,217,601.27-
  减:现金的期初余额53,217,601.27-26,676,610.18-
  现金及现金等价物的净增加额-23,774,815.15-26,540,991.09-
公告日期2025-08-222025-04-252025-04-252024-10-29
审计意见(境内)标准无保留意见
TOP↑